Dr. Jason Robert Guertin is a researcher at the Centre de recherche du CHU de Québec – Laval University and an assistant professor in the Department of Preventive and Social Medicine of Université Laval’s Faculty of Medicine.

Financial evaluation is a pivotal component of health technology assessment. It aims to support decision-makers to establish if adopting a novel health technology represents the most efficient use of available resources. Considering that healthcare demands are continuously on the rise, and budgets are overstretched, many health technology assessment units in Canada and abroad are examining the option of reassessing the value of previously adopted technologies using observational economic revaluations. Dr. Guertin’s research program focuses on the various components of economic evaluations and revaluations conducted within an observational setting. More recently, his work has focused on: 1) the development of novel methods aimed at addressing limits associated with observational economic evaluations; 2) evaluating the impact of chronic diseases on patients’ health-related quality of life in Quebec and Canada; and 3) the economic evaluation of health technologies in the field of personalized medicine.

Hôpital Saint-Sacrement
1050 Chemin Sainte-Foy
J1-09B
Québec, QC
Canada G1S 4L8
+1 418-525-4444, extension 82516
jason-robert.guertin@crch... jason.guertin@fmed.ulaval...

Latest news

74 entries « ‹ 1 of 8 › »

Gagnon R, Hébert LJ, Guertin JR, Berthelot S, Desmeules F, Perreault K

Integration of primary contact physiotherapists in the emergency department for individuals presenting with minor musculoskeletal disorders: Protocol for an economic evaluation

Journal Article

PLoS One, 18 (9), 2023.

Abstract | Links:

Diop A, Sirois C, Guertin JR, Schnitzer ME, Candas B, Cossette B, Poirier P, Brophy J, Mésidor M, Blais C, Hamel D, Tadrous M, Lix L, Talbot D

Marginal structural models with latent class growth analysis of treatment trajectories: Statins for primary prevention among older adults

Journal Article

Stat Methods Med Res, 32 (11), 2023.

Abstract | Links:

You Y, Simonyan D, Bureau A, Gagnon E, Albert C, Guertin JR, Tarride JE, Brown JP, Michou L

Molecular test of Paget's disease of bone in families not linked to SQSTM1 gene mutations

Journal Article

Bone Rep, 18 , 2023.

Abstract | Links:

Marx T, Moore L, Talbot D, Guertin JR, Lachapelle P, Blais S, Singbo N, Simonyan D, Lavallée J, Zada N, Shahrigharahkoshan S, Huard B, Olivier P, Mallet M, Létourneau M, Lafrenière M, Archambault PM, Berthelot S

A value-based comparison of the management of respiratory diseases in walk-in clinics and emergency departments

Journal Article

CJEM, 25 (5), 2023.

Abstract | Links:

Nguyen HM, Lindsay C, Baradaran M, Guertin JR, Nshimyumukiza L, Soukkhaphone B, Reinharz D

Development of a discrete choice experiment questionnaire to elicit preferences by pregnant women and policymakers for the expansion of non-invasive prenatal screening

Journal Article

PLoS One, 18 (6), 2023.

Abstract | Links:

Moore L, Bérubé M, Belcaid A, Turgeon AF, Taljaard M, Fowler R, Yanchar N, Mercier É, Paquet J, Stelfox HT, Archambault P, Berthelot S, Guertin JR, Haas B, Ivers N, Grimshaw J, Lapierre A, Ouyang Y, Sykes M, Witteman H, Lessard-Bonaventure P, Gabbe B, Lauzier F,

Evaluating the effectiveness of a multifaceted intervention to reduce low-value care in adults hospitalized following trauma: a protocol for a pragmatic cluster randomized controlled trial

Journal Article

Implement Sci, 18 (1), 2023.

Abstract | Links:

Chu C, Gomes T, Antoniou T, Wong WWL, Janjua N, Guertin JR, Schwartz KL, Feld J, Kwong J, Tadrous M

The impact of expanded access to direct acting antivirals for Hepatitis C virus on patient outcomes in Canada

Journal Article

PLoS One, 18 (8), 2023.

Abstract | Links:

Conombo B, Guertin JR, Hoch JS, Lauzier F, Turgeon AF, Stelfox HT, Moore L

Potential Avoidable Costs of Low-Value Clinical Practices in Acute Injury Care in an Integrated Canadian Provincial Trauma System

Journal Article

JAMA Surg, 158 (9), 2023.

| Links:

Michou L, Gamache P, Guertin JR, Tarride JE, Brown JP, Jean S

Prevalence and incidence of Paget's disease of bone: Temporal trend over 20 years in the province of Quebec, Canada

Journal Article

Bone, 176 , 2023.

Abstract | Links:

Nguyen HM, Baradaran M, Daigle G, Nshimyumukiza L, Guertin JR, Reinharz D

Pregnant women's and policymakers' preferences for the expansion of noninvasive prenatal screening: A discrete choice experiment approach study

Journal Article

Health Sci Rep, 6 (8), 2023.

Abstract | Links:

74 entries « ‹ 1 of 8 › »
Signaler des ajouts ou des modifications

Active projects

  • Coûts des maladies cardiovasculaires et des problèmes de santé mentale attribuables aux contraintes psychosociales au travail : Une étude longitudinale de 22 ans auprès de 9 000 cols blancs., from 2016-07-01 to 2024-03-31
  • Création d’une macro automatisée permettant d’estimer les coûts engendrés par des patients au sein des bases de données médico-administratives du Québec., from 2023-10-01 to 2024-09-30
  • Création d’une macro standardisée et validée permettant l’ajustement pour l’inflation des données économiques comprises dans les données médico-administratives, from 2022-08-01 to 2024-03-31
  • Étude de l'éco-efficience du port de l'équipement de protection individuelle contre la COVID-19 dans les urgences pour un contexte post-pandémique, from 2021-10-01 to 2024-03-31
  • PEGASUS-2 - PErsonalized Genomics for prenatal Abnormalities Screening USing maternal blood : Towards First Tier Screening and Beyond, from 2018-04-01 to 2024-03-31
  • Pilot study of a community pharmacy-based program to enhance adherence to adjuvant endocrine therapy among breast, from 2019-10-01 to 2025-03-31
  • Real World Clinical and Economic Burden of Severe Burn Injuries, from 2023-02-06 to 2025-02-05
  • Real World Clinical and Economic Burden of Severe Burn Injuries, from 2023-10-01 to 2026-09-30
  • Reducing low-value practices in acute trauma care: a pragmatic cluster randomized controlled trial, from 2023-04-01 to 2027-03-31
  • Réseaux thématiques - Réseau de thérapie cellulaire, tissulaire et génique du Québec (ThéCell), from 2023-04-01 to 2024-03-31
  • Soutenir l'utilisation d'une approche par cycle de vie au sein d'évaluations économiques en médecine régénératrice, from 2023-07-01 to 2027-06-30
  • Supporting the use of early economic evaluations within the regenerative medicine field, from 2023-04-01 to 2025-01-31
  • The right care, for the right patient, at the right time, by the right provider: A value-based comparison of the management of ambulatory respiratory diseases in walk-in clinics, primary care physician practices and emergency departments, from 2021-10-01 to 2025-03-31
  • The right care, for the right patient, at the right time, by the right provider: A value-based comparison of the management of ambulatory respiratory diseases in walk-in clinics, primary care physician practices and emergency departments, from 2020-04-01 to 2024-03-31

Recently finished projects

  • A multicenter skin research group focusing on novel treatment for epidermolysis, from 2022-12-01 to 2023-11-30
  • Adaptation of a standardized self-reported cost questionnaire specific for the severe burn injury population (BI-CoPaQ), from 2022-10-18 to 2023-10-17
  • Audit & Feedback Module Targeting Low-Value Clinical Practices in Injury Care: an Economic Evaluation, from 2020-04-01 to 2023-03-31
  • Clinical validity and clinical utility of a screening test for Paget's disease of bone, from 2019-03-01 to 2023-03-31
  • Étude préclinique et pharmacoépidémiologique de l’impact du dutastéride dans l’étiopathogenèse et la progression de la maladie de Parkinson, from 2021-04-01 to 2023-08-31
  • How to better manage infectious diseases in ER by triage with molecular mini-panels for the rapid detection of highly transmissible pathogens, from 2018-10-01 to 2022-09-30
  • Infrastructure de l'évaluation économique en médecine régénératrice, from 2020-04-01 to 2023-03-31
  • Optimisation des approches méthodologiques utilisées dans le cadre d’évaluations économiques basées sur des données observationnelles, from 2019-07-01 to 2023-06-30
  • Optimisation des approches méthodologiques utilisées dans le cadre d’évaluations économiques basées sur des données observationnelles, from 2019-07-01 to 2023-06-30
  • Programme de soutien aux nouveaux chercheurs, from 2019-07-01 to 2022-06-30
  • Quand innovations technologique et organisationnelle vont de pair: Un modèle collaboratif pour rendre l'oncogénétique plus agile, accessible et efficiente, from 2020-04-01 to 2023-10-27
  • Real-world effectiveness and cost-effectiveness of novel hepatitis C treatments, from 2020-04-01 to 2022-03-31
  • Real-World Evaluation of the Efficacy, Safety and Cost-Effectiveness of Statins for Primary Prevention of Cardiovascular Disease Among the Elderly – A Causal Perspective to Treatment Trajectory Analysis, from 2019-10-01 to 2023-03-31
  • The right care, for the right patient, at the right time, by the right provider: A value-based comparison of the management of ambulatory respiratory diseases in walk-in clinics, primary care physician practices and emergency departments, from 2021-03-01 to 2022-02-28
Data provided by the Université Laval research projects registery